Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03291054
Title Epacadostat and Pembrolizumab in Patients With GIST
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Richard D. Carvajal
Indications

gastrointestinal stromal tumor

Therapies

Epacadostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.